Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
RAPT Therapeutics raised $250 million by selling 8.3 million shares at $30 each, with an option for underwriters to buy more.
RAPT Therapeutics priced a public offering of 8.3 million shares at $30 each, raising about $250 million before expenses, with underwriters holding an option to buy 1.25 million more shares.
The offering, managed by several investment banks, is set to close around October 23, 2025, subject to standard conditions.
Shares are being offered under a prior SEC shelf registration.
The company warns that actual results may differ due to market and regulatory risks, as outlined in its SEC filings.
4 Articles
RAPT Therapeutics recaudó $250 millones vendiendo 8.3 millones de acciones a $30 cada una, con una opción para que los aseguradores compraran más.